Methyl 4,6-dichloropyrimidine-5-carboxylate, 95.0%, 100g

(4-(Naphthalen-1-yl(phenyl)amino)phenyl)boronic acid, 95+%, 5g

(4'-Cyano-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-methyl-carbamic acid tert-butyl ester, 250mg

Methyl 3,5-dibromobenzoate, 95.0%, 500g

(2E)-1-(2,4-dimethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Petri dishes without aeration lugs, 90 x 14 mm 825 pcs

(2E)-3-(2-ethoxyphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

Spiro[3.5]nonan-2-one, 97%, 100mg

tert-Butyl 3-((3-bromopyridin-2-yl)oxy)azetidine-1-carboxylate, 95.0%, 250mg

(propylsulfanyl)methanimidamide hydrobromide, 95.0%, 10g

(S)-2-Aminopent-4-ynoic acid, 95.0%, 250mg

Etifoxine, 99.96%, 1g

3,5-Dimethylbenzaldehyde>96.0%(GC)5g